MyPharmacy+

Ossimend Tablet

Manufactured By Ulterius Pharmaceuticals Private Limited

Salt Synonyms

Rs. 180.50

MRP 190.00

(5% OFF)

Includes all taxes

Package SIZE

strip of 10 tablets

Price may vary depending on the product batch*

100% Authentic
Products

Free
Shipping*

Products
Return Policy

Information about Ossimend Tablet

Uses / Indications:

Use as directed on the label or as advised by your healthcare provider.

Introduction:

Ossimend Tablet may help deal with pain and inflammation of joints. It may help maintain bone and joint health. It can be effective in dealing with bone loss and weakness. Moreover it can help combat swelling and stiffness of joints.

How to use:

This tablet can help regulate calcium levels in the body|It may help in the proper absorption of calcium and other nutrients|It can support bone teeth and joint health|This tablet can help enhance the mobility of joints

Description:

Helps in recovery from bone injuries and fractures|Prevents metabolic syndrome|Improves bone density and functions|Supports bone joint and teeth health

Benefits:

Safety Advise:

Read the label carefully before use|Do not exceed the recommended dosage|Store in a cool and dry place away from direct sunlight|Keep out of reach of children

Ossimend Tablet

Manufactured By Ulterius Pharmaceuticals Private Limited

Salt Synonyms

Rs. 180.50

MRP 190.00

Includes all taxes

Package SIZE

Available Substitutes

1-CC Oral Suspension Sugar Free

Azure Pharmaceuticals

1 Tree Co Q 10 Veg Capsule

Saisir Global Technologies Pvt Ltd

1 Tree Omega 3 6 9 Veg Capsule

Saisir Global Technologies Pvt Ltd

1 Tree Sleep Tight Oral Spray Strawberry

Saisir Global Technologies Pvt Ltd

10 AM Vegetable Capsule

Kachhela Medex Pvt Ltd

Uses / Indications:

Introduction:

How to use:

Description:

Benefits:

Safety Advise:

If you miss a dose:

Fact Box:

Primary Use:

Common Side Effects:

Alcohol Interaction:

Pregnancy Interaction:

Lactation Interaction:

Driving Interaction:

Kidney Interaction:

Liver Interaction:

Q&A: